Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
The European Journal of Neuroscience
|
April 27, 2026
Continuous Theta Burst Stimulation Inhibits Contralesional Parietal and Occipital Activity During Imagined Movements After Stroke
Justine R Magnuson, Cristina Rubino, Sara M Klick, et al.
Behavioural Brain Research
|
September 15, 2006
Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains
Sheryl S Moy, Jessica J Nadler, Nancy B Young, et al.
Molecular Cell
|
July 28, 2015
An Interactive Database for the Assessment of Histone Antibody Specificity
Scott B Rothbart, Bradley M Dickson, Jesse R Raab, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2014
Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors
Lan Wang, Mark Stanley, Jason W Boggs, et al.
Genomics
|
February 13, 2001
Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms
J L Reiter, D W Threadgill, G D Eley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist
T J Opgenorth, A L Adler, S V Calzadilla, et al.
Journal of Medicinal Chemistry
|
March 29, 2014
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization
Terry D Crawford, Chudi O Ndubaku, Huifen Chen, et al.
Journal of Medicinal Chemistry
|
October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitors
Emily J Hanan, Anne van Abbema, Kathy Barrett, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 14, 2017
Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance
Terry D Crawford, Steffan Vartanian, Alexandre Côté, et al.
Journal of Medicinal Chemistry
|
August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1
Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
The European Journal of Neuroscience
|
April 27, 2026
Continuous Theta Burst Stimulation Inhibits Contralesional Parietal and Occipital Activity During Imagined Movements After Stroke
Justine R Magnuson, Cristina Rubino, Sara M Klick, et al.
Behavioural Brain Research
|
September 15, 2006
Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains
Sheryl S Moy, Jessica J Nadler, Nancy B Young, et al.
Molecular Cell
|
July 28, 2015
An Interactive Database for the Assessment of Histone Antibody Specificity
Scott B Rothbart, Bradley M Dickson, Jesse R Raab, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 21, 2014
Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors
Lan Wang, Mark Stanley, Jason W Boggs, et al.
Genomics
|
February 13, 2001
Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms
J L Reiter, D W Threadgill, G D Eley, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1996
Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist
T J Opgenorth, A L Adler, S V Calzadilla, et al.
Journal of Medicinal Chemistry
|
March 29, 2014
Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization
Terry D Crawford, Chudi O Ndubaku, Huifen Chen, et al.
Journal of Medicinal Chemistry
|
October 16, 2012
Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitors
Emily J Hanan, Anne van Abbema, Kathy Barrett, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 14, 2017
Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance
Terry D Crawford, Steffan Vartanian, Alexandre Côté, et al.
Journal of Medicinal Chemistry
|
August 5, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1
Alexander M Taylor, Chris Bailey, Lisa D Belmont, et al.
Page
of 8